Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07614906 · ClinicalTrials.gov registry record
Nitric Oxide Consumption as a Predictor of Vasospasm in Subarachnoid Hemorrhage
A clinical trial, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- 40
- Enrollment target
NCT07614906: Recruiting study, sponsored by Massachusetts General Hospital.
NCT07614906 is a clinical trial that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07614906 is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
Study Summary
The goal of this observational study is to understand if angiographic cerebral vasospasm (CV) can be predicted by levels of nitric oxide (NO) consumption in patients with aneurysmal subarachnoid hemorrhage (SAH). To reach this goal, the investigators will compare NO consumption levels in SAH and non-SAH patients. NO consumption levels will be analyzed from samples of participants' cerebral spinal fluid (CSF).
Primary Outcome
Measurement taken from cerebrospinal fluid using nitric oxide consumption analyzer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-03-03 |
| Est. Completion | 2027-06 |
What NCT07614906 shows while recruiting
NCT07614906 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT07614906 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07614906 about?
NCT07614906 is a clinical study titled "Nitric Oxide Consumption as a Predictor of Vasospasm in Subarachnoid Hemorrhage". The goal of this observational study is to understand if angiographic cerebral vasospasm (CV) can be predicted by levels of nitric oxide (NO) consumption in patients with aneurysmal subarachnoid hemorrhage (SAH). To reach this goal, the investigators will compare NO consumption levels in SAH and non...
What is the current status of trial NCT07614906?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2024-03-03. Estimated completion is 2027-06.
Who is sponsoring clinical trial NCT07614906?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI